Sagimet Biosciences (SGMT) Financials: Revenue & Earnings
SGMT$10.64+0.22 +2.13%
$346.75M
Market Cap
—
P/E
—
Forward P/E
—
Score
Sagimet Biosciences (SGMT) Financials: Revenue & Earnings
SGMT price $10.64 +0.22 +2.13%
- Ticker
- SGMT
- Price
- $10.64
- Change
- +0.22 +2.13%
- Market cap ?
- $346.75M
- Beta ?
- 3.49
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
SGMT fair value $16.32. Price $10.64. Price is 35% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 168.06K. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 32.58M. Net debt -34.94M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.25 | — | 166.67K |
| 2026-08-11 | -0.26 | -0.25 | — | — |
| 2026-05-12 | -0.33 | -0.39 | — | — |
| 2026-03-11 | -0.29 | -0.43 | — | 1.11M |
| 2025-11-13 | -0.40 | -0.41 | — | — |
| 2025-08-13 | -0.32 | -0.52 | — | — |
| 2025-05-08 | -0.56 | -0.79 | — | — |
| 2025-03-12 | -0.50 | -0.65 | — | — |
| 2024-11-14 | -0.45 | -0.47 | — | — |
| 2024-08-14 | -0.25 | -0.34 | — | — |
| 2024-05-15 | -0.23 | -0.41 | — | — |
| 2024-03-25 | -0.78 | -0.58 | — | — |
| 2023-11-13 | -0.35 | -1.02 | 2.00M | — |
| 2023-07-14 | -35.80 | -0.50 | — | — |
| 2023-03-31 | -0.30 | — | — | — |
| 2022-12-31 | -0.32 | — | — | — |
| 2022-09-30 | -0.34 | — | — | — |
| 2022-06-30 | -0.32 | — | — | — |
| 2022-03-31 | -0.39 | — | — | — |
| 2021-03-31 | -0.25 | — | — | — |
| 2020-03-31 | -0.18 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Kemble George | Buy | 24.37K | $6.36 | 154.99K |
| 2026-08-14 | Kemble George | Buy | 326.62K | $6.36 | 2.08M |
| 2026-08-14 | Kemble George | Sell | 350.99K | $10.23 | 3.59M |
| 2026-08-14 | Kemble George | Sell | 326.62K | $6.36 | 2.08M |
| 2026-08-14 | Kemble George | Sell | 24.37K | $6.36 | 154.99K |
| 2026-08-11 | Kemble George | Sell | 9.75K | $6.36 | 62.02K |
| 2026-08-11 | Kemble George | Buy | 10.46K | $6.36 | 66.49K |
| 2026-08-11 | Kemble George | Buy | 9.75K | $6.36 | 62.02K |
| 2026-08-11 | Kemble George | Sell | 20.21K | $9.95 | 201.15K |
| 2026-08-11 | Kemble George | Sell | 10.46K | $6.36 | 66.49K |
| 2026-07-20 | Happel David | Sell | 64.05K | $7.76 | 497.07K |
| 2026-07-20 | Rozek Elizabeth | Sell | 10.54K | $7.76 | 81.83K |
| 2026-07-20 | Kemble George | Sell | 18.84K | $7.46 | 140.53K |
| 2026-06-12 | SEIDENBERG BETH C | Buy | 39.57K | $6.48 | 256.39K |
| 2026-06-12 | Hoelscher Paul W. | Buy | 39.57K | $6.48 | 256.39K |
| 2026-06-12 | Jarrett Jennifer | Buy | 39.57K | $6.48 | 256.39K |
| 2026-06-12 | GRAMMER ELIZABETH A | Buy | 39.57K | $6.48 | 256.39K |
| 2026-06-12 | Kemble George | Buy | 39.57K | $6.48 | 256.39K |
| 2026-06-12 | Phillips Anne M. | Buy | 39.57K | $6.48 | 256.39K |
| 2026-05-28 | Chauche Thierry | Buy | 50.00K | $7.27 | 363.50K |
| 2026-05-28 | Grauer Andreas | Buy | 35.00K | $7.27 | 254.45K |
| 2026-05-28 | Rozek Elizabeth | Buy | 100.00K | $7.27 | 727.00K |
| 2026-05-28 | Happel David | Buy | 300.00K | $7.27 | 2.18M |
| 2026-04-20 | Grauer Andreas | Buy | 264.76K | $6.44 | 1.71M |
| 2026-04-20 | Grauer Andreas | Other | 0 | — | — |
| 2026-02-19 | Rozek Elizabeth | Buy | 44.00K | — | — |
| 2026-02-19 | Rozek Elizabeth | Buy | 88.00K | $5.38 | 473.44K |
| 2026-02-19 | Martins Eduardo Bruno | Buy | 44.00K | — | — |
| 2026-02-19 | Martins Eduardo Bruno | Buy | 88.00K | $5.38 | 473.44K |
| 2026-02-19 | Happel David | Buy | 128.00K | — | — |
| 2026-02-19 | Happel David | Buy | 256.00K | $5.38 | 1.38M |
| 2026-02-19 | Chauche Thierry | Buy | 88.00K | $5.38 | 473.44K |
| 2026-02-19 | Chauche Thierry | Buy | 44.00K | — | — |
| 2026-02-10 | Happel David | Sell | 12.10K | $5.36 | 64.86K |
| 2026-02-10 | Chauche Thierry | Sell | 1.31K | $5.36 | 7.03K |
| 2026-02-10 | Martins Eduardo Bruno | Sell | 3.64K | $5.36 | 19.51K |
| 2026-02-10 | Rozek Elizabeth | Sell | 2.62K | $5.36 | 14.05K |
| 2025-11-20 | Kemble George | Sell | 37.69K | $7.69 | 289.98K |
| 2025-11-04 | Rozek Elizabeth | Buy | 9.86K | — | — |
| 2025-11-04 | Rozek Elizabeth | Buy | 13.37K | $7.61 | 101.72K |
| 2025-07-21 | Happel David | Sell | 65.48K | $9.13 | 598.12K |
| 2025-07-21 | Martins Eduardo Bruno | Sell | 8.28K | $9.13 | 75.61K |
| 2025-07-21 | Rozek Elizabeth | Sell | 10.78K | $9.13 | 98.47K |
| 2025-06-09 | Walbert Timothy P | Buy | 32.25K | $5.33 | 171.89K |
| 2025-06-09 | SEIDENBERG BETH C | Buy | 32.25K | $5.33 | 171.89K |
| 2025-06-09 | Phillips Anne M. | Buy | 27.27K | $5.33 | 145.34K |
| 2025-06-09 | Kemble George | Buy | 32.25K | $5.33 | 171.89K |
| 2025-06-09 | Jarrett Jennifer | Buy | 27.27K | $5.33 | 145.34K |
| 2025-06-09 | Hoelscher Paul W. | Buy | 32.25K | $5.33 | 171.89K |
| 2025-06-09 | GRAMMER ELIZABETH A | Buy | 32.25K | $5.33 | 171.89K |
| 2025-06-06 | SEIDENBERG BETH C | Buy | 28.52K | $5.56 | 158.58K |
| 2025-02-06 | Martins Eduardo Bruno | Buy | 138.00K | $4.71 | 649.98K |
| 2025-02-06 | Martins Eduardo Bruno | Buy | 34.00K | — | — |
| 2025-02-06 | Happel David | Buy | 116.00K | — | — |
| 2025-02-06 | Happel David | Buy | 472.00K | $4.71 | 2.22M |
| 2025-02-06 | Rozek Elizabeth | Buy | 34.00K | — | — |
| 2025-02-06 | Rozek Elizabeth | Buy | 138.00K | $4.71 | 649.98K |
| 2025-02-06 | Chauche Thierry | Buy | 69.00K | $4.71 | 324.99K |
| 2025-02-06 | Chauche Thierry | Buy | 17.00K | — | — |
| 2024-08-01 | Jarrett Jennifer | Buy | 113.89K | $3.48 | 396.35K |
| 2024-08-01 | Phillips Anne M. | Buy | 113.89K | $3.48 | 396.35K |
| 2024-08-01 | Jarrett Jennifer | Other | 0 | — | — |
| 2024-08-01 | Phillips Anne M. | Other | 0 | — | — |
| 2024-07-23 | Kemble George | Sell | 23.62K | $3.17 | 74.83K |
| 2024-07-19 | Martins Eduardo Bruno | Sell | 8.36K | $3.10 | 25.91K |
| 2024-07-19 | Rozek Elizabeth | Sell | 10.91K | $3.10 | 33.83K |
| 2024-07-19 | Kemble George | Sell | 14.06K | $3.10 | 43.60K |
| 2024-06-05 | Walbert Timothy P | Buy | 9.28K | $4.64 | 43.05K |
| 2024-06-05 | SEIDENBERG BETH C | Buy | 51.46K | $4.64 | 238.77K |
| 2024-06-05 | Parsey Merdad | Buy | 51.46K | $4.64 | 238.77K |
| 2024-06-05 | Hoelscher Paul W. | Buy | 9.28K | $4.64 | 43.05K |
| 2024-06-05 | GRAMMER ELIZABETH A | Buy | 51.46K | $4.64 | 238.77K |
| 2024-05-06 | Chauche Thierry | Buy | 587.18K | $4.28 | 2.51M |
| 2024-05-06 | Chauche Thierry | Other | 0 | — | — |
| 2024-04-01 | Walbert Timothy P | Buy | 73.01K | $5.23 | 381.86K |
| 2024-04-01 | Hoelscher Paul W. | Buy | 73.01K | $5.23 | 381.86K |
| 2024-04-01 | Walbert Timothy P | Sell | 0 | — | — |
| 2024-04-01 | Hoelscher Paul W. | Other | 0 | — | — |
| 2024-03-26 | Happel David | Buy | 12.10K | $5.27 | 63.73K |
| 2024-01-29 | SANDELL SCOTT D | Sell | 850.00K | — | — |
| 2024-01-29 | SANDELL SCOTT D | Buy | 260.95K | — | — |
| 2024-01-29 | SANDELL SCOTT D | Buy | 7.00K | — | — |
| 2024-01-29 | SANDELL SCOTT D | Sell | 260.95K | — | — |
| 2024-01-29 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 850.00K | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Buy | 30.00K | $16.00 | 480.00K |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Buy | 13.40K | $0.79 | 10.65K |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 662 | $16.00 | 10.59K |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Buy | 3.77M | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Buy | 37.68K | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 11.36M | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 37.68K | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 23.04M | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 14.66M | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 11.36M | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 13.40K | $0.79 | 10.65K |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 237.89M | — | — |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 1.30M | — | — |
| 2023-07-18 | GRAMMER ELIZABETH A | Buy | 49.53K | $8.74 | 432.92K |
| 2023-07-18 | GRAMMER ELIZABETH A | Sell | 49.53K | $8.74 | 432.92K |
| 2023-07-13 | NEW ENTERPRISE ASSOCIATES 13 LP | Sell | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 130, holders +37 vs prior quarter. Ownership 96.38%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 6.58M | 5.78M | +722.03% | 50.83M |
| BALYASNY ASSET MANAGEMENT L.P. | 3.63M | 3.63M | New | 28.03M |
| WOODLINE PARTNERS LP | 3.00M | 2.00M | +199.78% | 23.20M |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.93M | 2.93M | New | 22.63M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.57M | 1.47M | +133.53% | 19.84M |
| CALIGAN PARTNERS LP | 2.50M | 2.50M | New | 19.32M |
| BVF INC/IL | 2.50M | 2.50M | New | 19.32M |
| AFFINITY ASSET ADVISORS, LLC | 2.50M | 1.63M | +187.77% | 19.31M |
| FEDERATED HERMES, INC. | 2.09M | 2.09M | +267085.02% | 16.13M |
| GREAT POINT PARTNERS LLC | 2.03M | 2.03M | New | 15.69M |
| STATE STREET CORP | 2.00M | 1.87M | +1449.13% | 15.42M |
| SATURN V CAPITAL MANAGEMENT LP | 1.48M | 1.48M | New | 11.44M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.44M | 1.13M | +366.53% | 11.17M |
| BLUE OWL CAPITAL HOLDINGS LP | 1.26M | 926.67K | +277.55% | 9.74M |
| BAKER BROS. ADVISORS LP | 953.00K | 0 | 0.00% | 7.37M |
| MILLENNIUM MANAGEMENT LLC | 937.02K | 74.72K | +8.67% | 7.24M |
| ABERDEEN GROUP PLC | 847.70K | 847.70K | New | 6.55M |
| GOLDMAN SACHS GROUP INC | 759.09K | 589.83K | +348.48% | 5.87M |
| HHLR ADVISORS, LTD. | 724.80K | 0 | 0.00% | 5.60M |
| AMERIPRISE FINANCIAL INC | 581.22K | 581.22K | New | 4.49M |
| VESTAL POINT CAPITAL, LP | 535.45K | 535.45K | New | 4.14M |
| NORTHERN TRUST CORP | 468.38K | 412.87K | +743.77% | 3.62M |
| BOOTHBAY FUND MANAGEMENT, LLC | 464.10K | 464.10K | New | 3.59M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 437.50K | 437.50K | New | 3.38M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 415.00K | 415.00K | New | 3.21M |
Earnings and financials
Sagimet Biosciences Inc. (SGMT) trades at $10.64, with a market cap of $346.75M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn